CMPX R&D Expenses
Compass Therapeutics · R&D Expenses
CMPX R&D Expenses
Latest reported$59.45Mperiod ending
CMPX R&D Expenses ($27.10M → $59.45M)
Annual R&D Expenses
High-resolution chart · PNG
CMPX r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 55,969,000 | |
| 42,342,000 | |
| 38,120,000 | |
| 29,997,000 | |
| 20,337,000 | |
| 14,904,000 | |
| 22,449,000 | |
| 27,095,000 |